Boehringer Ingelheim Pharmaceuticals Building 10

Boehringer Ingelheim Pharmaceuticals - Building 10Boehringer Ingelheim Pharmaceuticals - Building 10Boehringer Ingelheim Pharmaceuticals - Building 10Boehringer Ingelheim Pharmaceuticals - Building 10Boehringer Ingelheim Pharmaceuticals - Building 10

slideslideslideslideslide

*
Boehringer Ingelheim Pharmaceuticals - Building 10Boehringer Ingelheim Pharmaceuticals - Building 10Boehringer Ingelheim Pharmaceuticals - Building 10Boehringer Ingelheim Pharmaceuticals - Building 10

Strategic scientific interaction

LocationRidgefield, Connecticut

RecognitionIIDA Wisconsin Design Award, First Place

When the pharmaceutical company Boehringer Ingelheim embarked on a major expansion of its North American facilities, it was not simply to house more scientists. It was to expand science itself — pioneering important research in immunology and inflammation, and combating cardiovascular disease.

The striking campus features buildings set atop two steep hills with a valley and wetland areas running between. Building 10 curves gracefully with the natural contours of the land, offering views of the rolling Connecticut Hills while minimizing its own ecological impact. A welcoming entrance provides a gathering place for the research division, offering a café and conference space, in addition to consolidated and centralized administrative functions. Perhaps most importantly, a three-story, light-filled atrium connects related buildings and provides a central interaction hub for the scientific community.

quote

Buildings are constructed for a purpose and the purpose of this building is a noble one - to discover new treatments for human disease. But buildings should also inspire those within its walls, and Building 10, despite its very modest name, achieves this.

Dr. Terence KellyVice PresidentMedicinal Chemistry

©2018 Flad ArchitectsFacebookInstagramLinkedIn